2 items2 sources1 stocks
Seeking Alpha-Nov 6, 03:25 PM
RenovoRx maintains $3.75M-$4.25M 2026 revenue guidance as it targets 36 active cancer centers
RenovoRx maintains $3.75M-$4.25M 2026 revenue guidance as it targets 36 active cancer centers(摘要待生成)
The Motley Fool-Nov 6, 05:13 PM
RenovoRx (RNXT) Q3 2026 Earnings Call Transcript
RenovoRx (RNXT) Q3 2026 Earnings Call Transcript(摘要待生成)